Tea Pemovska, PhD

49 posts

Tea Pemovska, PhD

@TPemovska

Cancer chemical systems biologist, interested in personalised medicine, HT-drug screening, haematological malignancies, Senior Postdoctoral Researcher MUW

Vienna, Austria Katılım Ekim 2019

181 Takip Edilen126 Takipçiler

Tea Pemovska, PhD retweetledi

HemaSphere Journal (prelim IF = 11.3)@Hemasphere_EHA·11 Haz

The EXALT-2 trial (NCT04470947) compares genomic-based precision medicine (gPM), functional precision medicine (fPM), and physicians' choice for relapsed/refractory blood cancer patients. Both gPM and fPM efficiently guide therapy decisions, with fPM showing shorter reporting times and higher actionable target identification. Read more here👉bit.ly/42tyYHO @TPemovska @PhilippStaber

HemaSphere Journal (prelim IF = 11.3) tweet media

English

395

Tea Pemovska, PhD@TPemovska·17 Haz

Want to learn more about #functional precision medicine and meet world-leading experts? Join us in Copenhagen 25-27 Sept. 2024 for the EHA-SfPM Precision Medicine Meeting @EHA_Hematology @TheSFPM . Abstract submission is still open. ehaweb.org/meetings/preci…

English

520

Tea Pemovska, PhD@TPemovska·3 Eki

@HeidiA_Neubauer @VetmeduniVienna Congrats Heidi!

Nederlands

Heidi Neubauer@HeidiA_Neubauer·2 Eki

Thrilled to be starting my new position as Assistant Professor together with my group at the Institute for Medical Biochemistry @VetmeduniVienna !

Vetmeduni@VetmeduniVienna

Wir begrüßen heute nicht nur unsere #Erstis recht herzlich, sondern auch unsere 3 neuen (Assistenz-)Professorinnen ☺🎉 → Janina Burk, Professorin Physiologie → Valeria Marasco, Ass.professorin Wildtierphysiologie → Heidi Neubauer, Ass.professorin Molekulare Zellbiologie

English

4.9K

Tea Pemovska, PhD retweetledi

Philipp Staber@PhilippStaber·19 Nis

@TheSFPM Great to see, early work of @TPemovska recognized in an excellent talk

English

Tea Pemovska, PhD@TPemovska·29 Mar

@CCCZ_USZ @MedUni_Wien @WennerbergLab @UCPH_BRIC @wolfgangkhuber @EMBLHeidelberg Thank you for the invitation, honored to be part of a fantastic meeting!

English

Comprehensive Cancer Center Zurich@CCCZ_USZ·29 Mar

Three international guests now in Session 3. Thank you @TPemovska, of @MedUni_Wien Krister Wennerberg, of @WennerbergLab / @UCPH_BRIC and @wolfgangkhuber, of @EMBLHeidelberg uzh.zoom.us/j/61750493691?…

Comprehensive Cancer Center Zurich tweet media

English

541

Tea Pemovska, PhD retweetledi

MedUni Wien@MedUni_Wien·11 Şub

Today is International #WomenInScienceDay! 👩🔬 For today, we would like to shine the spotlight on our female #ResearcheroftheMonth from 2022. Congratulations to the #WomeninSTEM on their projects. To the collected videos! ➡️ bit.ly/3YvHMbr @womenscienceday

English

1.4K

Tea Pemovska, PhD retweetledi

Snijder Lab@snijderlab·20 Eyl

A big thanks goes to all the patients, clinical partners and collaborators @PhilippStaber, @CK5haus, @TPemovska, @GregVladimer, @giuliosf, @exscientiaAI and funding bodies @ETH_en, @dfg_public, @ERC_Research and @snsf_ch. 7/7

English

Tea Pemovska, PhD@TPemovska·8 Eyl

@CeMM_News @gsf_lab @MedUni_Wien Thank you @CeMM_News

English

CeMM@CeMM_News·8 Eyl

Congratulations to Tea Pemovska (@TPemovska), #CeMM alumna & former postdoc in Giulio Superti-Furga's group (@gsf_lab), for being elected @MedUni_Wien #ResearcherOfTheMonth for her research on #HematologicCancer! 👏 🎉 📄 Link to the publication➡️ bit.ly/3AK1nu8

MedUni Wien@MedUni_Wien

What therapies are used for aggressive #bloodcancer and #lymphoidcancer? And are they effective? Our #ResearcheroftheMonth Christoph Kornauth and @tpemovska from #MedUniVienna have established an innovative translational approach. Learn more! ➡️ bit.ly/3B287oo

English

Tea Pemovska, PhD retweetledi

MedUni Wien@MedUni_Wien·1 Eyl

English

Tea Pemovska, PhD retweetledi

Anthony Letai MD PhD@DrTonyLetai·28 Haz

Some great functional precision medicine here! @TheSFPM

Cancer Discovery@CD_AACR

Check out Cancer Discovery's newest collection on Precision Medicine and Therapeutic Resistance! bit.ly/3NjU7cE

English

Tea Pemovska, PhD@TPemovska·14 Haz

@giuliosf @MedUni_Wien @simona_saluzzo @a_kammerlander @billrothhaus Thank you @giuliosf

English

Giulio Superti-Furga@giuliosf·13 Haz

@MedUni_Wien @simona_saluzzo @TPemovska @a_kammerlander @billrothhaus congratulations!!

English

MedUni Wien@MedUni_Wien·13 Haz

Wir gratulieren @simona_saluzzo, @tpemovska und @a_kammerlander zu den Dora Brücke-Teleky Awards! 🏆 Mit dem Award zeichnen unser Alumni Club und das @billrothhaus Publikationen von #Postdocs aus. Mehr zu den Papers und zur Preisverleihung am 21. Juni! ➡️ bit.ly/3AwLdTD

Deutsch

Tea Pemovska, PhD retweetledi

MedUni Wien@MedUni_Wien·13 Haz

Congratulations to @simona_saluzzo, @tpemovska and @a_kammerlander on the Dora Brücke-Teleky Awards! 🏆 With the award, our Alumni Club and the @billrothhaus honor publications by #postdocs. More about the papers and the award ceremony on 21 June! ➡️ bit.ly/3AwLdTD

English

Tea Pemovska, PhD retweetledi

Anthony Letai MD PhD@DrTonyLetai·23 May

Regulators, academics, investors and industry need to get together @theSFPM.

Keith Ligon@KeithLigon5

Compelling well designed clinical trials of diagnostics are the path-urgent need for pathologists and diagnostic companies to join forces. ‘No real clear path’: Insurance coverage for cutting-edge diagnostics remains a major challenge... statnews.com/2022/05/20/cov… via @statnews

English

Tea Pemovska, PhD retweetledi

OncoAlert@OncoAlert·3 Haz

DAY1⃣ #ASCO22 @CD_AACR @OncoAlert 🚨Recap‼️ 5⃣Great papers presented by @ElizSMcKenna LINK🚫NO PAY WALL🧱 tinyurl.com/CDclinicaltria… @DanaFarber @MDAndersonNews @MGHCancerCenter @CK5haus @TPemovska @giuliosf @BerendSnijder @PhilippStaber @weoncologists @MedUni_Wien @imedverse

English

Tea Pemovska, PhD retweetledi

Philipp Staber@PhilippStaber·13 Nis

Super-proud that EXALT, our FPM study, was selected by The Cancer Discovery editors in this collection of impactful precision medicine articles: aacrjournals.org/collection/70/… Thanks to: @ElizSMcKenna, @CD_AACR , @CK5haus, @TPemovska, @GregVladimer, @giuliosf, @BerendSnijder

English

Tea Pemovska, PhD retweetledi

Cancer Discovery@CD_AACR·10 Şub

Check out the papers featured on the cover of this month’s Cancer Discovery: Individualized therapies for hematologic malignancies. bit.ly/3JhHnSm By @CK5haus, @TPemovska, Ingrid Simonitsch-Klupp, @giuliosf, @BerendSnijder, @PhilippStaber, and colleagues ⬇

English

Mirella Bucci@mirellabucci·15 Ara

curated drug screen cancer cells have weaknesses target these pathways #haiku #paperoftheday from @TPemovska, @giuliosf, & colleagues in @NatureComms: nature.com/articles/s4146… #openaccess

English

Tea Pemovska, PhD@TPemovska·15 Ara

@mirellabucci @giuliosf @NatureComms @mirellabucci Thank you for highlighting our work.

English

Tea Pemovska, PhD@TPemovska·15 Ara

@KaanBoztug @mrebsamen @gsf_lab @NatureComms @MedUni_Wien @giuliosf @CeMM_News Thank you @KaanBoztug

English

Kaan Boztug@KaanBoztug·14 Ara

@mrebsamen @gsf_lab @NatureComms @TPemovska @MedUni_Wien Great work! Congratulations @TPemovska @giuliosf @CeMM_News !

English

Superti-Furga Lab@gsf_lab·14 Ara

Check out the new study from the GSF Lab published in @NatureComms today with first author @TPemovska and collaborators from @MedUni_Wien where we show how vulnerabilities of cancer cell lines are determined through a collection of metabolic drugs.

CeMM@CeMM_News

Scientists from Giulio Superti-Furga's group at CeMM (@gsf_lab) have used a drug library (CLIMET) to target a variety of metabolic pathways & identify sensitivities among 15 #MyeloidLeukemia cell lines, which could open future cancer therapy options ➡️ bit.ly/3pTejIM

English

Tea Pemovska, PhD@TPemovska·15 Ara

@kporkka @giuliosf @bigenzahn @gsf_lab @CeMM_News @MedUni_Wien Thank you @kporkka

English

Kimmo Porkka@kporkka·15 Ara

@TPemovska @giuliosf @bigenzahn @gsf_lab @CeMM_News @MedUni_Wien Well done Tea, Giulio & team, congrats! 🎉

English

Tea Pemovska, PhD@TPemovska·14 Ara

Very honored to share our newest paper on targeting cancer cell metabolism in myeloid leukemias out today in Nature Communications. Thanks to all the collaborators and funders. Particularly @giuliosf, @bigenzahn, @gsf_lab & StaberLab. Conducted @CeMM_News & @MedUni_Wien.

CeMM@CeMM_News

The study “Metabolic drug survey highlights cancer cell dependencies and vulnerabilities” was published in the journal @NatureComms on 14 December 2021. nature.com/articles/s4146…

English

Keşfet

@PhilippStaber @EHA_Hematology @TheSFPM @HeidiA_Neubauer @VetmeduniVienna @CCCZ_USZ @MedUni_Wien @WennerbergLab